Unibios Holdings S.A. Overview
Get informed when a big investor buys or sells
+ Follow13.55%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for BIOSK.AT is 13.55%. That is above the sector sector average of 11.85%. Investors often review this figure alongside Unibios Holdings S.A.'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, BIOSK.AT currently prints 13.55% for ROE, while the sector average sits near 11.85%. That is roughly 14.4% above the sector mean. Large gaps often invite a closer look at Unibios Holdings S.A.'s growth, margins, and balance sheet.
Return on Equity shows how effectively Unibios Holdings S.A. converts resources into returns. At 13.55%, BIOSK.AT may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BIOSK.AT's ROE (13.55%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
